Literature DB >> 18819520

Evaluation of the toxicity of oligonucleotide/cationic nanoemulsion complexes on Hep G2 cells through MTT assay.

M Fraga1, M Laux, G Rejane Dos Santos, B Zandoná, C Dos Santos Giuberti, M C de Oliveira, Matte U da Silveira, H Ferreira Teixeira.   

Abstract

The purpose of this study was to evaluate the toxicity of the oligonucleotide/cationic nanoemulsion complexes on Hep G2 cells through MTT assay. Complexes exhibit droplet size, zeta potential and viscosity of approximately 270 nm, +50mV, and 1.0 cP. Different parameters which may have an influence on toxicity results obtained by MTT assay, i.e. cells number, concentration of MTT reagent and the addition of Soerensen's glycine buffer were first evaluated. In the optimized conditions (1 x 10(4) cells and 0.5 mg/mL MTT), the overall results showed that the addition of increasing amounts of complexes (or nanoemulsions) lead to a progressive toxicity on cells attributed to the presence of the cationic lipid stearylamine in the formulations, whatever the medias's pH is. The IC50 was approximately 200 microg/ml. Such results open interesting perspectives on the use of these nanoemulsions as oligonucleotide delivery systems for Hep G2 cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18819520

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  4 in total

1.  Activity of Sanguinarine against Candida albicans Biofilms.

Authors:  Hua Zhong; Dan-Dan Hu; Gan-Hai Hu; Juan Su; Shuang Bi; Zhuo-Er Zhang; Zheng Wang; Ri-Li Zhang; Zheng Xu; Yuan-Ying Jiang; Yan Wang
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Influence of phospholipid composition on cationic emulsions/DNA complexes: physicochemical properties, cytotoxicity, and transfection on Hep G2 cells.

Authors:  Michelle Fraga; Fernanda Bruxel; Valeska Lizzi Lagranha; Helder Ferreira Teixeira; Ursula Matte
Journal:  Int J Nanomedicine       Date:  2011-10-07

3.  Development of a new rutin nanoemulsion and its application on prostate carcinoma PC3 cell line.

Authors:  Mohammad Ahmad; - Sahabjada; Juber Akhtar; Arshad Hussain; - Badaruddeen; Md Arshad; Anuradha Mishra
Journal:  EXCLI J       Date:  2017-05-31       Impact factor: 4.068

4.  Sphingomyelin-Based Nanosystems (SNs) for the Development of Anticancer miRNA Therapeutics.

Authors:  Surasa Nagachinta; Belen Lopez Bouzo; Abi Judit Vazquez-Rios; Rafael Lopez; Maria de la Fuente
Journal:  Pharmaceutics       Date:  2020-02-22       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.